We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$21.8B
AUM Growth
+$3.61B
Cap. Flow
+$3.01B
Cap. Flow %
13.83%
Top 10 Hldgs %
18.11%
Holding
5,525
New
1,399
Increased
1,367
Reduced
1,397
Closed
1,345

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.91%
2 Communication Services 1.69%
3 Technology 1.67%
4 Financials 0.69%
5 Consumer Staples 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARWR icon
4151
CALL
Arrowhead Research
ARWR
$11.7B
$21K ﹤0.01%
13,600
-13,300
-49% -$21.5K
PKD
4152
DELISTED
Parker Drilling Company
PKD
$20K ﹤0.01%
+1,002
New +$22.5K
FCEL icon
4153
PUT
FuelCell Energy
FCEL
$1.56B
$19K ﹤0.01%
41
-2
-5% -$885
SLS icon
4154
PUT
SELLAS Life Sciences
SLS
$1.87B
$19K ﹤0.01%
22
+10
+83% +$8.7K
VVUS
4155
DELISTED
Vivus Inc
VVUS
$19K ﹤0.01%
1,606
-1,275
-44% -$14K
VVUS
4156
PUT
DELISTED
Vivus Inc
VVUS
$19K ﹤0.01%
1,560
-180
-10% -$1.98K
CYTR
4157
CALL
DELISTED
CytRx Corp
CYTR
$18K ﹤0.01%
+4,350
New +$14.9K
TNDM icon
4158
Tandem Diabetes Care
TNDM
$1.22B
$17K ﹤0.01%
2,079
-420
-17% -$3.88K
NCTY
4159
The9 Ltd
NCTY
$67M
$15K ﹤0.01%
42
ALIM
4160
CALL
DELISTED
Alimera Sciences
ALIM
$15K ﹤0.01%
+733
New +$15.7K
ATHX
4161
DELISTED
Athersys, Inc. Common Stock
ATHX
$15K ﹤0.01%
406
-401
-50% -$14.9K
GNMX
4162
PUT
DELISTED
Aevi Genomic Medicine Inc
GNMX
$15K ﹤0.01%
+10,800
New +$15.6K
PGH
4163
PUT
DELISTED
Pengrowth Energy Corporation
PGH
$14K ﹤0.01%
+17,300
New +$15.8K
OBE
4164
PUT
Obsidian Energy
OBE
$653M
$13K ﹤0.01%
+1,514
New +$13.5K
ASXC
4165
DELISTED
Asensus Surgical, Inc.
ASXC
$13K ﹤0.01%
1,416
+207
+17% +$1.97K
PGH
4166
CALL
DELISTED
Pengrowth Energy Corporation
PGH
$13K ﹤0.01%
+15,800
New +$14.4K
WAC
4167
DELISTED
Walter Investment Mgt Corp
WAC
$12K ﹤0.01%
11,740
-9,407
-44% -$10.8K
FTEK icon
4168
Fuel Tech
FTEK
$45.5M
$11K ﹤0.01%
12,914
+1,689
+15% +$1.47K
RGLS
4169
CALL
DELISTED
Regulus Therapeutics
RGLS
$11K ﹤0.01%
+90
New +$15K
SDRL
4170
DELISTED
Seadrill Limited Common Stock
SDRL
$11K ﹤0.01%
+110
New +$17.3K
UNXL
4171
CALL
DELISTED
Uni-Pixel, Inc.
UNXL
$11K ﹤0.01%
27,400
-32,400
-54% -$17.2K
RPRX
4172
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$11K ﹤0.01%
22,900
-18,300
-44% -$13.3K
VNCE icon
4173
Vince Holding Corp
VNCE
$76.2M
$9K ﹤0.01%
1,818
+15
+0.8% +$107
ASXC
4174
PUT
DELISTED
Asensus Surgical, Inc.
ASXC
$9K ﹤0.01%
+1,015
New +$9.66K
NAVB
4175
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$8K ﹤0.01%
+777
New +$7.68K

Similar funds

Wolverine Trading's Q2 2017 Portfolio in Review

As of Q2 2017, Wolverine Trading held 5,525 positions worth $21.8B, up 20% from $18.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Wolverine Trading deployed $3.01B of net new capital in Q2 2017, opening 1,399 new positions and adding to 1,367 existing holdings. Its largest new stake was Tesla: 2,094,870 shares worth $50.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.2% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $40.7M trimmed.

  • Wolverine Trading's largest Q2 2017 buy was Tesla: 2,094,870 shares worth $50.4M.
  • Wolverine Trading added most to State Street SPDR S&P 500 ETF Trust in Q2 2017, an estimated $156M increase.
  • Wolverine Trading's biggest Q2 2017 reduction was Berkshire Hathaway Class A, cutting an estimated $40.7M.
  • Wolverine Trading fully exited Vanguard Short-Term Corporate Bond ETF in Q2 2017, selling an estimated $8.09M.
  • Wolverine Trading's ten largest holdings make up 18% of its $21.8B portfolio in Q2 2017.
  • Wolverine Trading opened 1,399 new positions and closed 1,345 in Q2 2017.
  • Wolverine Trading's portfolio value rose 20% quarter-over-quarter to $21.8B.

Based on Wolverine Trading's 13F filing for Q2 2017, filed 14 Aug 2017.